Oliveto Joseph 4
4 · Milestone Pharmaceuticals Inc. · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Oliveto Joseph
DirectorPresident and CEO
Transactions
- Sale
Common Shares
2026-01-07$2.25/sh−500$1,125→ 346,721 total - Sale
Common Shares
2026-01-08$2.25/sh−43,000$96,750→ 303,721 total
Footnotes (2)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.265 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.